Cargando…
Herpes viruses and human papilloma virus in nasal polyposis and controls()
INTRODUCTION: Chronic rhinosinusitis with nasal polyps is a multifactorial disease entity with an unclear pathogenesis. Contradictory data exist in the literature on the potential implication of viral elements in adult patients with chronic rhinosinusitis. OBJECTIVE: To compare the prevalence of hum...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442677/ https://www.ncbi.nlm.nih.gov/pubmed/26480900 http://dx.doi.org/10.1016/j.bjorl.2015.08.010 |
_version_ | 1784782870817013760 |
---|---|
author | Ioannidis, Dimitrios Lachanas, Vasileios A. Florou, Zoe Bizakis, John G. Petinaki, Efthymia Skoulakis, Charalampos E. |
author_facet | Ioannidis, Dimitrios Lachanas, Vasileios A. Florou, Zoe Bizakis, John G. Petinaki, Efthymia Skoulakis, Charalampos E. |
author_sort | Ioannidis, Dimitrios |
collection | PubMed |
description | INTRODUCTION: Chronic rhinosinusitis with nasal polyps is a multifactorial disease entity with an unclear pathogenesis. Contradictory data exist in the literature on the potential implication of viral elements in adult patients with chronic rhinosinusitis. OBJECTIVE: To compare the prevalence of human herpes viruses (1–6) and Human Papilloma Virus in adult patients with chronic rhinosinusitis with nasal polyps and healthy controls. METHODS: Viral DNA presence was evaluated by real-time polymerase chain reaction application to nasal polyps specimens from 91 chronic rhinosinusitis with nasal polyps patients and nasal turbinate mucosa from 38 healthy controls. RESULTS: Epstein–Barr virus positivity was higher in nasal polyps (24/91; 26.4%) versus controls (4/38; 10.5%), but the difference did not reach significance (p = 0.06). Human herpes virus-6 positivity was lower in nasal polyps (13/91; 14.29%) versus controls (10/38; 26.32%, p = 0.13). In chronic rhinosinusitis with nasal polyps group, 1 sample was herpes simplex virus-1-positive (1/91; 1.1%), and another was cytomegalovirus-positive (1/91; 1.1%), versus none in controls. No sample was positive for herpes simplex virus-2, varicella-zoster virus, high-risk-human papilloma viruses (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) and low-risk-human papilloma viruses (6, 11). CONCLUSION: Differences in Epstein–Barr virus and human herpes virus-6 positivity among patients with chronic rhinosinusitis with nasal polyps and healthy controls are not statistically significant, weakening the likelihood of their implication in chronic rhinosinusitis with nasal polyps pathogenesis. |
format | Online Article Text |
id | pubmed-9442677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94426772022-09-09 Herpes viruses and human papilloma virus in nasal polyposis and controls() Ioannidis, Dimitrios Lachanas, Vasileios A. Florou, Zoe Bizakis, John G. Petinaki, Efthymia Skoulakis, Charalampos E. Braz J Otorhinolaryngol Original Article INTRODUCTION: Chronic rhinosinusitis with nasal polyps is a multifactorial disease entity with an unclear pathogenesis. Contradictory data exist in the literature on the potential implication of viral elements in adult patients with chronic rhinosinusitis. OBJECTIVE: To compare the prevalence of human herpes viruses (1–6) and Human Papilloma Virus in adult patients with chronic rhinosinusitis with nasal polyps and healthy controls. METHODS: Viral DNA presence was evaluated by real-time polymerase chain reaction application to nasal polyps specimens from 91 chronic rhinosinusitis with nasal polyps patients and nasal turbinate mucosa from 38 healthy controls. RESULTS: Epstein–Barr virus positivity was higher in nasal polyps (24/91; 26.4%) versus controls (4/38; 10.5%), but the difference did not reach significance (p = 0.06). Human herpes virus-6 positivity was lower in nasal polyps (13/91; 14.29%) versus controls (10/38; 26.32%, p = 0.13). In chronic rhinosinusitis with nasal polyps group, 1 sample was herpes simplex virus-1-positive (1/91; 1.1%), and another was cytomegalovirus-positive (1/91; 1.1%), versus none in controls. No sample was positive for herpes simplex virus-2, varicella-zoster virus, high-risk-human papilloma viruses (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) and low-risk-human papilloma viruses (6, 11). CONCLUSION: Differences in Epstein–Barr virus and human herpes virus-6 positivity among patients with chronic rhinosinusitis with nasal polyps and healthy controls are not statistically significant, weakening the likelihood of their implication in chronic rhinosinusitis with nasal polyps pathogenesis. Elsevier 2015-09-08 /pmc/articles/PMC9442677/ /pubmed/26480900 http://dx.doi.org/10.1016/j.bjorl.2015.08.010 Text en © 2015 Associac¸ão Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Article Ioannidis, Dimitrios Lachanas, Vasileios A. Florou, Zoe Bizakis, John G. Petinaki, Efthymia Skoulakis, Charalampos E. Herpes viruses and human papilloma virus in nasal polyposis and controls() |
title | Herpes viruses and human papilloma virus in nasal polyposis and controls() |
title_full | Herpes viruses and human papilloma virus in nasal polyposis and controls() |
title_fullStr | Herpes viruses and human papilloma virus in nasal polyposis and controls() |
title_full_unstemmed | Herpes viruses and human papilloma virus in nasal polyposis and controls() |
title_short | Herpes viruses and human papilloma virus in nasal polyposis and controls() |
title_sort | herpes viruses and human papilloma virus in nasal polyposis and controls() |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442677/ https://www.ncbi.nlm.nih.gov/pubmed/26480900 http://dx.doi.org/10.1016/j.bjorl.2015.08.010 |
work_keys_str_mv | AT ioannidisdimitrios herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols AT lachanasvasileiosa herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols AT florouzoe herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols AT bizakisjohng herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols AT petinakiefthymia herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols AT skoulakischaralampose herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols |